DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 9.15% to $11.92 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.51% to 19,630.20 and the Dow Jones Industrial Average rising 0.78% to 43,487.83.
The stock's fall snapped a three-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 80.74% below its 52-week high of $61.90, which the company reached on July 31st.
The stock underperformed when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.80% to $4.36, Fortress Biotech Inc. (FBIO) fell 2.09% to $1.87, and Viking Therapeutics Inc. $(VKTX)$ rose 0.28% to $32.65.
Trading volume (185,983) remained 100,737 below its 50-day average volume of 286,720.
Data source: Dow Jones Market Data, FactSet. Data compiled January 17, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 17, 2025 17:26 ET (22:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。